<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171231038152N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-09-16</date_registration>
      <primary_sponsor>Fasa University of Medical Sciences</primary_sponsor>
      <public_title>The impact on the sensitivity of the method of removing suicidal thoughts</public_title>
      <acronym></acronym>
      <scientific_title>Study The Efficacy of Eye Movements Desensitization and Reprocessing on the Severity of Suicidal Thoughts in patients with major depressive disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-01-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28992</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: 70 cases of patients with major depressive disorder who have had suicidal thoughts, mental hospital by doctor in psychiatry were admitted, for sampling available. after a thorough explanation of the objectives of the study and informed consent, with the random assignment method of sand in one of two group Control (n = 35) and experimental (n = 35).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Major depressive disorder, suicidal thoughts.</hc_freetext>
      <i_freetext>Intervention 1: "Intervention group": In order to intervene in the intervention group, the researcher initially acquainted the patient with an eye-de-dysmotilator and re-treatment and familiarity with her confidence in the study. An Eye Dehumidification and Reprocessing Method is an eight-stage method that emphasizes the physiological information processing and treatment of mental health problems. In the first stage, injuries from suicidal thoughts and the first thought of suicide with the trauma were identified and necessary measures were taken for treatment. The second stage was the explanation of the process, the effects, the description of the expectations of the patient and the preparation of the patient for the implementation of the treatment. Third, the identification of memories, images, symbols, the most disturbing visual image associated with suicidal thoughts, patient beliefs about the incident, physical senses associated with post-incident beliefs, and a positive belief in identifying and prioritizing previous beliefs. Replaced. The fourth step is to focus on the patient's negative belief, follow-up of the therapist's fingertip within the patient's vision, asking the patient to follow the movements of the fingers, and repeating this until the patient's mental discomfort level reaches zero or at least. In the fifth stage, rehabilitation and empowerment of the patient's positive beliefs were made. Sixth stage of the discomfort and remaining physical pressure were controlled and focused on the level of reduction and fading during the treatment. The seventh stage of the frightening images, the thoughts or emotions experienced during the treatment, the events described, the thoughts, conditions, dreams, memories by the patient, and the stability of the patient, the completion of the treatment sessions and preparing the patient to leave the treatment sessions was ensured. . Eighth stage The patient focused on previously processed goals and assessed the extent of achieving therapeutic goals. One of the therapeutic components in the eye-retardation and re-processing method is the visual follow-up of the therapist's finger motion as the patient eventually implies a traumatic scene. The patient was following the rapid movements of the therapist's finger across his field of vision, with rapid eye movement. The therapist's finger was about 30 cm from the eyes of the subject and moved from right to left and vice versa in the patient's field of vision. This move included two rounds to the sides in one second, which was a cycle, and each 24-12 cycles were a set. After each set, the therapist asked the patient to stop the visualization of the scene and lean back into his chair and breathe deeply. The process is repeated to the extent that the levels of mental disorientation units are zero or minimized based on the patient's level of motivation and need for it. At last, the Beck Suicidal Thoughts Severity Questionnaire was completed by patients. Intervention 2: "Control group": In the control group, no interventions are performed by the investigator. Patients receive their routine treatments. At the first session and the end of the third week, the individual characteristics and the severity of the suicidal thoughts will be completed again.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Part of the data, such as information relating to the main outcomes are sharing ghlble

When:
A year later out of print results

To whom:
Researchers working at the University

Conditions:
Any data type is not allowed on analisis

Where to obtain:
Abdolhadi Jahanfar, Yasoj, Emam sajad hospital,00989171453841

How to obtain:
The demand through theEmail

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Jahanfar Abdolhadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>N.21, 4 Aabozar4</address>
        <city>Yasoj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7591674489</zip>
        <telephone>+98 74 3322 0162</telephone>
        <email>jahanfarhadi91@gmail.com</email>
        <affiliation>Fasa University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Behnam moghadam Mohamad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahadat 12, Bagher Khan Blvd, Yasuj</address>
        <city>yasoj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7591674489</zip>
        <telephone>+98 74 3322 0165</telephone>
        <email>mbehnammoghadam1363@yahoo.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>, the diagnostic criteria for major depressive disorder has on the basis of the scale of the DSM-IV and has suicidal thoughts suicidal thoughts based on ascale, Beck
Patients do not have a history of suicide
Strabismus is vision problems will not be
A history of febrile seizure will not be
The age range is between twenty and sixty years</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>63 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The patient is unable to tolerate the eye with movements sensitivity therapy tool and process again
Sending patients to other medical centers, do not complete the treatment sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F32.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, single episode, severe with psychotic features</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>"Intervention group": In order to intervene in the intervention group, the researcher initially acquainted the patient with an eye-de-dysmotilator and re-treatment and familiarity with her confidence in the study. An Eye Dehumidification and Reprocessing Method is an eight-stage method that emphasizes the physiological information processing and treatment of mental health problems. In the first stage, injuries from suicidal thoughts and the first thought of suicide with the trauma were identified and necessary measures were taken for treatment. The second stage was the explanation of the process, the effects, the description of the expectations of the patient and the preparation of the patient for the implementation of the treatment. Third, the identification of memories, images, symbols, the most disturbing visual image associated with suicidal thoughts, patient beliefs about the incident, physical senses associated with post-incident beliefs, and a positive belief in identifying and prioritizing previous beliefs. Replaced. The fourth step is to focus on the patient's negative belief, follow-up of the therapist's fingertip within the patient's vision, asking the patient to follow the movements of the fingers, and repeating this until the patient's mental discomfort level reaches zero or at least. In the fifth stage, rehabilitation and empowerment of the patient's positive beliefs were made. Sixth stage of the discomfort and remaining physical pressure were controlled and focused on the level of reduction and fading during the treatment. The seventh stage of the frightening images, the thoughts or emotions experienced during the treatment, the events described, the thoughts, conditions, dreams, memories by the patient, and the stability of the patient, the completion of the treatment sessions and preparing the patient to leave the treatment sessions was ensured. . Eighth stage The patient focused on previously processed goals and assessed the extent of achieving therapeutic goals. One of the therapeutic components in the eye-retardation and re-processing method is the visual follow-up of the therapist's finger motion as the patient eventually implies a traumatic scene. The patient was following the rapid movements of the therapist's finger across his field of vision, with rapid eye movement. The therapist's finger was about 30 cm from the eyes of the subject and moved from right to left and vice versa in the patient's field of vision. This move included two rounds to the sides in one second, which was a cycle, and each 24-12 cycles were a set. After each set, the therapist asked the patient to stop the visualization of the scene and lean back into his chair and breathe deeply. The process is repeated to the extent that the levels of mental disorientation units are zero or minimized based on the patient's level of motivation and need for it. At last, the Beck Suicidal Thoughts Severity Questionnaire was completed by patients</i_keyword>
      <i_keyword>"Control group": In the control group, no interventions are performed by the investigator. Patients receive their routine treatments. At the first session and the end of the third week, the individual characteristics and the severity of the suicidal thoughts will be completed again</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Suicide thought. Timepoint: The intensity of suicidal thoughts in the first session and three weeks later at the latest meeting of the measure to be. Method of measurement: beck suicide scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Fasa University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-12-12</approval_date>
        <contact_name>Ethics committee of fasa University of Medical Sciences</contact_name>
        <contact_address>N.21, 4 Abozar Yasoj Kohgilouyeh-va-Boyrahmad Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
